hydroxychloroquine has been researched along with Cerebral Infarction in 2 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Cerebral Infarction: The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hossri, S | 1 |
| Shadi, M | 1 |
| Hamarsha, Z | 1 |
| Schneider, R | 1 |
| El-Sayegh, D | 1 |
| Guillan, M | 1 |
| Villacieros-Alvarez, J | 1 |
| Bellido, S | 1 |
| Perez-Jorge Peremarch, C | 1 |
| Suarez-Vega, VM | 1 |
| Aragones-Garcia, M | 1 |
| Cabrera-Rojo, C | 1 |
| Fernandez-Ferro, J | 1 |
2 other studies available for hydroxychloroquine and Cerebral Infarction
| Article | Year |
|---|---|
Clinically significant anticardiolipin antibodies associated with COVID-19.
Topics: Adult; Antibodies, Anticardiolipin; Antibodies, Monoclonal, Humanized; Anticoagulants; Antiphospholi | 2020 |
Unusual simultaneous cerebral infarcts in multiple arterial territories in a COVID-19 patient.
Topics: Aged; Anti-Bacterial Agents; Anticoagulants; Antimalarials; Azithromycin; Betacoronavirus; Ceftriaxo | 2020 |